DECOMPOPT proposes a new generation paradigm combining optimization with conditional diffusion models to achieve desired properties in drug discovery.
Advancements in structure-based drug design focus on improving unconditional aspects, neglecting specificity. Introducing the Delta Score as a metric to enhance specificity.
Proposing Binding-Adaptive Diffusion Models (BINDDM) to enhance 3D molecule generation for structure-based drug design.
The author proposes Binding-Adaptive Diffusion Models (BINDDM) to enhance 3D molecule generation by extracting essential binding subcomplexes from protein-ligand interactions and incorporating cross-hierarchy interaction nodes for improved performance.